REGN Earnings

Quarterly EPS
$12.40
Q3 2024
$8.53
Q4 2024
$7.58
Q1 2025
$13.24
Q2 2025
$14.09
Q3 2025
$8.20
Q4 2025
$6.99
Q1 2026
$12.62
Q2 2026
Latest Revenue4.3B
Latest Net Income1.3B
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$12.624.3B1.3B+16.7%-4.7%
Q1 2026$6.993.6B727.2M+19.0%-7.8%
Q4 2025$8.203.9B844.6M+2.5%-3.9%
Q3 2025$14.093.8B1.5B+0.9%+13.6%
Q2 2025$13.243.7B1.4B+3.6%-0.1%
Q1 2025$7.583.0B808.7M-3.7%+13.1%
Q4 2024$8.533.8B917.7M+10.3%-21.7%
Q3 2024$12.403.7B1.3B+10.6%+30.8%
Q2 2024$13.253.5B1.4B
Q1 2024$6.703.1B722.0M
Q4 2023$10.903.4B1.2B
Q3 2023$9.483.4B1.0B
Regeneron Pharmaceuticals (REGN) — Earnings